SITC 2021 | Importance of patient’s gender when developing personalised immunotherapy

Name: Importance of patient’s gender when developing personalised immunotherapy
Uploaded: 2021-11-12T00:00:00Z
Duration: 43 s
Description: Dhifaf Sarhan, PhD, Karolinska Institute, Stockholm, Sweden, discusses the importance of taking into account the differences between the male and female microenvironment when developing targeted-immunotherapy. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.

Dhifaf Sarhan • 12 Nov 2021

SITC 2021

Pancreatic Cancer

Dhifaf Sarhan, PhD, Karolinska Institute, Stockholm, Sweden, discusses the importance of taking into account the differences between the male and female microenvironment when developing targeted-immunotherapy. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.